India has officially approved Ozempic (semaglutide), a once-a-week injection for adults with type 2 diabetes, which also aids in weight loss. This GLP-1 receptor analogue helps control blood sugar, offers cardiovascular protection, and supports healthier eating habits. While promising for India’s rising diabetes rates, users should be aware of potential side effects.
Muskan Rastogi, jailed in Meerut for allegedly murdering her husband with her lover, has tested positive for pregnancy in a preliminary examination, jail officials reported. […]
Abhay Devdas Nayak, a Bengaluru resident, faced court in Scotland. He is accused of threatening to bomb an easyJet flight. Nayak allegedly shouted “Allahu Akbar” […]
The Supreme Court has reversed the Bihar Legislative Council’s expulsion of RJD leader Sunil Kumar Singh for mocking Chief Minister Nitish Kumar, deeming the punishment […]